Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Expert Rev Precis Med Drug Dev. 2021 May 26;6(4):247–258. doi: 10.1080/23808993.2021.1930531

Figure 1:

Figure 1:

Current model of preventive cardiology incorporating the Pooled Cohort Equations to determine a rough estimation of risk that is then further refined with the use of validated biomarkers and other risk enhancers. The result of this refined estimation is then used to inform shared decision-making discussions with patients before selecting appropriate therapies.